JIANGSU NHWA PHARMACEUTICAL CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.24 CNY | -0.36% |
|
-5.32% | -17.99% |
| 06-20 | Nhwa Pharmaceutical's Penehyclidine Hydrochloride Injection Passes Regulatory Testing | MT |
| 06-20 | Nhwa Pharmaceutical Gets Registration Certificate for Pregabalin Capsules | MT |
Evolution of the average Target Price on Jiangsu Nhwa Pharmaceutical Co., LTD
Price target over the last 5 years
History of analyst recommendation changes
68903cc.BucCipR-OMc_a_lrVLz8h71nvPpR1btnNGEVyoCvdDU.UZJh_80ObJ9rA6kRZvWFsuo9jsgamfpKYlNXj9TrRk01rnK7xDtev05cqA~75e167d37219dd5297c599a0a30e11b0
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
22.24
CNY
Average target price
32.21
CNY
Spread / Average Target
+44.81%
High Price Target
37.5
CNY
Spread / Highest target
+68.62%
Low Price Target
28
CNY
Spread / Lowest Target
+25.90%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- 002262 Stock
- Consensus Jiangsu Nhwa Pharmaceutical Co., LTD
